A citation-based method for searching scientific literature

Nahid Tayebi, Barbara K Stubblefield, Joseph K Park, Eduard Orvisky, Jamie M Walker, Mary E LaMarca, Ellen Sidransky. Am J Hum Genet 2003
Times Cited: 84







List of co-cited articles
584 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA).
Kathleen S Hruska, Mary E LaMarca, C Ronald Scott, Ellen Sidransky. Hum Mutat 2008
408
39

The human glucocerebrosidase gene and pseudogene: structure and evolution.
M Horowitz, S Wilder, Z Horowitz, O Reiner, T Gelbart, E Beutler. Genomics 1989
343
30

Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease.
D L Stone, N Tayebi, E Orvisky, B Stubblefield, V Madike, E Sidransky. Hum Mutat 2000
152
28

Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease.
V Koprivica, D L Stone, J K Park, M Callahan, A Frisch, I J Cohen, N Tayebi, E Sidransky. Am J Hum Genet 2000
219
25

Gaucher disease: complexity in a "simple" disorder.
Ellen Sidransky. Mol Genet Metab 2004
266
21

Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.
E Sidransky, M A Nalls, J O Aasly, J Aharon-Peretz, G Annesi, E R Barbosa, A Bar-Shira, D Berg, J Bras, A Brice,[...]. N Engl J Med 2009
21


Parkinsonism among Gaucher disease carriers.
O Goker-Alpan, R Schiffmann, M E LaMarca, R L Nussbaum, A McInerney-Leo, E Sidransky. J Med Genet 2004
246
15

Occurrence of Parkinson's syndrome in type I Gaucher disease.
O Neudorfer, N Giladi, D Elstein, A Abrahamov, T Turezkite, E Aghai, A Reches, B Bembi, A Zimran. QJM 1996
300
14

Glucocerebrosidase mutations in subjects with parkinsonism.
Alicia Lwin, Eduard Orvisky, Ozlem Goker-Alpan, Mary E LaMarca, Ellen Sidransky. Mol Genet Metab 2004
264
14

Structure and organization of the human metaxin gene (MTX) and pseudogene.
G L Long, S Winfield, K W Adolph, E I Ginns, P Bornstein. Genomics 1996
40
27

Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3.
Ozlem Goker-Alpan, Raphael Schiffmann, Joseph K Park, Barbara K Stubblefield, Nahid Tayebi, Ellen Sidransky. J Pediatr 2003
94
13

Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.
Judith Aharon-Peretz, Hanna Rosenbaum, Ruth Gershoni-Baruch. N Engl J Med 2004
420
13

Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup.
Joseph K Park, Eduard Orvisky, Nahid Tayebi, Christine Kaneski, Mary E Lamarca, Barbara K Stubblefield, Brian M Martin, Raphael Schiffmann, Ellen Sidransky. Pediatr Res 2003
68
14

Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?
N Tayebi, J Walker, B Stubblefield, E Orvisky, M E LaMarca, K Wong, H Rosenbaum, R Schiffmann, B Bembi, E Sidransky. Mol Genet Metab 2003
224
11

Divergent phenotypes in Gaucher disease implicate the role of modifiers.
O Goker-Alpan, K S Hruska, E Orvisky, P S Kishnani, B K Stubblefield, R Schiffmann, E Sidransky. J Med Genet 2005
83
12

A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher's disease.
S Tsuji, P V Choudary, B M Martin, B K Stubblefield, J A Mayor, J A Barranger, E I Ginns. N Engl J Med 1987
289
10

Twin pairs showing discordance of phenotype in adult Gaucher's disease.
R H Lachmann, I R Grant, D Halsall, T M Cox. QJM 2004
109
10


X-ray structure of human acid-beta-glucosidase, the defective enzyme in Gaucher disease.
Hay Dvir, Michal Harel, Andrew A McCarthy, Lilly Toker, Israel Silman, Anthony H Futerman, Joel L Sussman. EMBO Rep 2003
195
10

The risk of Parkinson's disease in type 1 Gaucher disease.
Gilberto Bultron, Katherine Kacena, Daniel Pearson, Michael Boxer, Ruhua Yang, Swati Sathe, Gregory Pastores, Pramod K Mistry. J Inherit Metab Dis 2010
134
10

Metaxin is a component of a preprotein import complex in the outer membrane of the mammalian mitochondrion.
L C Armstrong, T Komiya, B E Bergman, K Mihara, P Bornstein. J Biol Chem 1997
100
9

Type 2 Gaucher disease: the collodion baby phenotype revisited.
D L Stone, W F Carey, J Christodoulou, D Sillence, P Nelson, M Callahan, N Tayebi, E Sidransky. Arch Dis Child Fetal Neonatal Ed 2000
56
14

Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype.
Eduard Orvisky, Joseph K Park, Mary E LaMarca, Edward I Ginns, Brian M Martin, Nahid Tayebi, Ellen Sidransky. Mol Genet Metab 2002
131
9

Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
N Tayebi, K J Reissner, E K Lau, B K Stubblefield, A C Klineburgess, B M Martin, E Sidransky. Pediatr Res 1998
50
16

Gaucher disease and parkinsonism: a phenotypic and genotypic characterization.
N Tayebi, M Callahan, V Madike, B K Stubblefield, E Orvisky, D Krasnewich, J J Fillano, E Sidransky. Mol Genet Metab 2001
158
9

Perinatal-lethal Gaucher disease.
C Mignot, A Gelot, B Bessières, F Daffos, M Voyer, F Menez, C Fallet Bianco, S Odent, D Le Duff, P Loget,[...]. Am J Med Genet A 2003
68
11

Increased incidence of Parkinson disease among relatives of patients with Gaucher disease.
Assaf Halperin, Deborah Elstein, Ari Zimran. Blood Cells Mol Dis 2006
96
9

Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.
O Goker-Alpan, B I Giasson, M J Eblan, J Nguyen, H I Hurtig, V M-Y Lee, J Q Trojanowski, E Sidransky. Neurology 2006
160
9

Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients.
Mirella Filocamo, Raffaella Mazzotti, Marina Stroppiano, Marco Seri, Fiorina Giona, Giancarlo Parenti, Stefano Regis, Fabio Corsolini, Stefania Zoboli, Rosanna Gatti. Hum Mutat 2002
41
19

Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
Z Gan-Or, N Giladi, U Rozovski, C Shifrin, S Rosner, T Gurevich, A Bar-Shira, A Orr-Urtreger. Neurology 2008
258
9

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.
Juliane Neumann, Jose Bras, Emma Deas, Sean S O'Sullivan, Laura Parkkinen, Robin H Lachmann, Abi Li, Janice Holton, Rita Guerreiro, Reema Paudel,[...]. Brain 2009
460
9

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Jérôme Stirnemann, Nadia Belmatoug, Fabrice Camou, Christine Serratrice, Roseline Froissart, Catherine Caillaud, Thierry Levade, Leonardo Astudillo, Jacques Serratrice, Anaïs Brassier,[...]. Int J Mol Sci 2017
297
9

GBA Analysis in Next-Generation Era: Pitfalls, Challenges, and Possible Solutions.
Stefania Zampieri, Silvia Cattarossi, Bruno Bembi, Andrea Dardis. J Mol Diagn 2017
28
28

Gaucher's disease variant characterised by progressive calcification of heart valves and unique genotype.
A Abrahamov, D Elstein, V Gross-Tsur, B Farber, Y Glaser, I Hadas-Halpern, S Ronen, M Tafakjdi, M Horowitz, A Zimran. Lancet 1995
153
8

Neuropathology provides clues to the pathophysiology of Gaucher disease.
Kondi Wong, Ellen Sidransky, Ajay Verma, Tonghui Mixon, Glenn D Sandberg, Laura K Wakefield, Alan Morrison, Alicia Lwin, Carlos Colegial, John M Allman,[...]. Mol Genet Metab 2004
321
8


LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase.
David Reczek, Michael Schwake, Jenny Schröder, Heather Hughes, Judith Blanz, Xiaoying Jin, William Brondyk, Scott Van Patten, Tim Edmunds, Paul Saftig. Cell 2007
343
8

Mutations for Gaucher disease confer high susceptibility to Parkinson disease.
Jun Mitsui, Ikuko Mizuta, Atsushi Toyoda, Ryo Ashida, Yuji Takahashi, Jun Goto, Yoko Fukuda, Hidetoshi Date, Atsushi Iwata, Mitsutoshi Yamamoto,[...]. Arch Neurol 2009
149
8

Identification of a novel recombinant mutation in Korean patients with Gaucher disease using a long-range PCR approach.
Seon-Yong Jeong, Seo-Jin Kim, Jeong-A Yang, Ji-Hee Hong, Su-Jin Lee, Hyon J Kim. J Hum Genet 2011
14
50

Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.
Ganqiang Liu, Brendon Boot, Joseph J Locascio, Iris E Jansen, Sophie Winder-Rhodes, Shirley Eberly, Alexis Elbaz, Alexis Brice, Bernard Ravina, Jacobus J van Hilten,[...]. Ann Neurol 2016
154
8

Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION.
Melissa Leija-Salazar, Fritz J Sedlazeck, Marco Toffoli, Stephen Mullin, Katya Mokretar, Maria Athanasopoulou, Aimee Donald, Reena Sharma, Derralynn Hughes, Anthony H V Schapira,[...]. Mol Genet Genomic Med 2019
42
16



Gaucher's disease with Parkinson's disease: clinical and pathological aspects.
B Bembi, S Zambito Marsala, E Sidransky, G Ciana, M Carrozzi, M Zorzon, C Martini, M Gioulis, M G Pittis, L Capus. Neurology 2003
106
7

Two novel polymorphic sequences in the glucocerebrosidase gene region enhance mutational screening and founder effect studies of patients with Gaucher disease.
E K Lau, N Tayebi, L J Ingraham, S L Winfield, V Koprivica, D L Stone, A Zimran, E I Ginns, E Sidransky. Hum Genet 1999
18
33

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.
W M Holleran, E I Ginns, G K Menon, J U Grundmann, M Fartasch, C E McKinney, P M Elias, E Sidransky. J Clin Invest 1994
221
7

Prediction of severity of Gaucher's disease by identification of mutations at DNA level.
A Zimran, J Sorge, E Gross, M Kubitz, C West, E Beutler. Lancet 1989
268
7

Mutation analysis of Gaucher disease patients from Argentina: high prevalence of the RecNciI mutation.
B Cormand, T L Harboe, L Gort, C Campoy, M Blanco, N Chamoles, A Chabás, L Vilageliu, D Grinberg. Am J Med Genet 1998
23
26

Hematologically important mutations: Gaucher disease.
Ernest Beutler, Terri Gelbart, C Ronald Scott. Blood Cells Mol Dis 2005
110
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.